Sulfanilamide Prices

Sulfanilamide Price Trend, Index and Forecast

Track the latest insights on sulfanilamide price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Sulfanilamide Prices Outlook Q2 2025

• USA: US$ 30780/MT
• China: US$ 20435/MT
• Germany: US$ 33460/MT
• South Korea: US$ 37500/MT
• Brazil: US$ 32660/MT

Sulfanilamide Price Chart

Get real-time access to monthly/quaterly/yearly prices, Request Sample

During the second quarter of 2025, sulfanilamide prices in the USA reached 30780 USD/MT in June. In the USA, sulfanilamide prices stayed steady, supported by consistent pharmaceutical demand and adequate domestic availability. Imports complemented supply chains, though stable raw material costs limited any strong upward momentum. Buyers adopted cautious procurement, aligning purchases with immediate needs. The absence of major disruptions in logistics or feedstock ensured smooth market flow. Overall, the US sulfanilamide market reflected stability, with balanced supply-demand dynamics and restrained market activity preventing significant price fluctuations during the quarter.

During the second quarter of 2025, sulfanilamide prices in China reached 20435 USD/MT in June. In China, sulfanilamide prices remained stable, supported by steady pharmaceutical sector consumption and strong domestic production capacity. Export activity was moderate, with regional demand taking precedence over international shipments. Raw material costs were steady, keeping production economics favorable and prices within a narrow range. Buyers followed cautious procurement patterns, meeting short-term requirements. With no major supply disruptions, the Chinese sulfanilamide market-maintained balance, marked by sufficient availability and consistent consumption, resulting in stable pricing throughout the quarter.

During the second quarter of 2025, the sulfanilamide prices in Germany reached 33460 USD/MT in June. In Germany, sulfanilamide prices reflected a stable to slightly soft tone, shaped by cautious buying trends from pharmaceutical and veterinary applications. Domestic supply was adequate, while imports ensured smooth availability across the market. Stable raw material values kept production costs in check, preventing significant fluctuations. Buyers avoided aggressive stockpiling, instead meeting immediate requirements. With balanced fundamentals and consistent but moderate demand, the German sulfanilamide market stayed steady, showing little volatility during the quarter while maintaining predictable trading patterns.

During the second quarter of 2025, the sulfanilamide prices in South Korea reached 37500 USD/MT in June. In South Korea, sulfanilamide prices remained stable, driven by steady demand from pharmaceutical intermediates and controlled supply conditions. Domestic producers maintained balanced operating rates, while imports supplemented availability when needed. Raw material costs stayed firm, supporting manageable production economics without causing major price swings. Buyers adopted conservative procurement strategies, aligning purchases with short-term needs. With no significant disruptions in supply chains or demand surges, the South Korean sulfanilamide market reflected steady fundamentals, ensuring stable pricing throughout the quarter.

During the second quarter of 2025, the sulfanilamide prices in Brazil reached 32660 USD/MT in June. In Brazil, sulfanilamide prices remained relatively stable, influenced by steady pharmaceutical sector demand and reliance on imports to meet domestic requirements. International market trends played a key role, though balanced global supply helped avoid sharp fluctuations. Buyers were cautious, focusing on short-term procurement and avoiding large-scale inventory buildup. Stable raw material values supported predictable pricing, while logistics remained smooth. Overall, the Brazilian sulfanilamide market displayed steady fundamentals, with adequate supply and moderate demand keeping prices within a stable range.

Sulfanilamide Prices Outlook Q2 2023

• USA: US$ 26587/MT
• China: US$ 20748/MT
• Germany: US$ 28636/MT

The price of sulfanilamide in the United States for Q2 2023 reached 26587 USD/MT in June.

The price trend for sulfanilamide in China concluded at 20748 USD/MT, nearing the end of Q2 2023.

The Q2 2023 sulfanilamide price was 28636 USD/MT in Germany.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the sulfanilamide prices.

Global Sulfanilamide Price Trend

The report offers a holistic view of the global sulfanilamide pricing trends in the form of sulfanilamide price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price levels but also provides insights into historical price of sulfanilamide, enabling stakeholders to understand past fluctuations and their underlying causes. The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed sulfanilamide demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Sulfanilamide Price Trend

Q2 2025:

As per the sulfanilamide price index, European sulfanilamide prices remained stable with a slightly soft tone due to cautious demand from pharmaceutical and veterinary applications. Producers maintained balanced operating rates to avoid inventory overhangs, while steady raw material costs kept production economics in check. Import flows were sufficient, ensuring smooth availability across the region. Buyers remained selective in procurement, focusing on immediate requirements rather than bulk purchases. Overall, the European sulfanilamide market reflected steady fundamentals, characterized by balanced supply and restrained demand activity.

Q2 2023:

European sulfanilamide prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed sulfanilamide price information for a comprehensive list of countries.

North America Sulfanilamide Price Trend

Q2 2025:

In North America, sulfanilamide prices stayed relatively stable, shaped by consistent demand from pharmaceutical manufacturing and controlled supply conditions. Domestic production was sufficient to meet market requirements, while imports supplemented availability without major disruptions. Buyers were cautious in procurement, with no rush toward stockpiling given predictable cost structures. Raw material stability ensured smooth production flows, keeping the market from sharp fluctuations. Overall, sulfanilamide prices in North America displayed steady fundamentals, supported by adequate supply and moderate but consistent consumption.

Q2 2023:

The analysis of sulfanilamide prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific data on sulfanilamide prices within the United States and Canada can also be provided.

Middle East and Africa Sulfanilamide Price Trend

Q2 2025:

The report explores the sulfanilamide trends and sulfanilamide price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices. 

In addition to region-wise data, information on sulfanilamide prices for countries can also be provided.

Asia Pacific Sulfanilamide Price Trend

Q2 2025:

In the Asia-Pacific region, sulfanilamide prices demonstrated stability supported by consistent demand from pharmaceutical intermediates. China and India, being major producers, kept supply chains well-balanced, though competitive pricing restrained significant upward trends. Feedstock costs remained steady, ensuring manageable production economics. Export opportunities were moderate, with regional consumption acting as the key driver. End-use industries adopted cautious procurement strategies, aligning purchases with near-term needs. Overall, APAC’s sulfanilamide market reflected balanced fundamentals, characterized by stable costs, steady demand, and well-maintained supply.

Q2 2023:

The sulfanilamide pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This analysis can be further extended to include detailed sulfanilamide prices for a comprehensive list of countries within the region.

Latin America Sulfanilamide Price Trend

Q2 2025:

In Latin America, sulfanilamide prices reflected stability with a slight downward bias due to subdued demand from the pharmaceutical and veterinary drug sectors. Import dependency kept the market closely tied to global trade flows, while steady raw material costs prevented major volatility. Buyers maintained conservative purchasing strategies, focusing on immediate needs rather than long-term stocking. Overall, balanced supply conditions, adequate inventories, and cautious market activity contributed to a relatively calm pricing environment, with little room for upward momentum.

This comprehensive review can be extended to include specific countries within the region.

Sulfanilamide Price Trend, Market Analysis, and News

IMARC's latest publication, “Sulfanilamide Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the sulfanilamide market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of sulfanilamide at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed sulfanilamide prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting sulfanilamide pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Sulfanilamide Industry Analysis

The global sulfanilamide market size reached US$ 39.60 Million in 2024. By 2033, IMARC Group expects the market to reach US$ 57.34 Million, at a projected CAGR of 3.99% during 2025-2033.

• The market is experiencing growth propelled by the increasing incidence of urinary tract infections (UTI), respiratory tract infections, and skin infections necessitating the ongoing use of effective antimicrobial agents like sulfanilamide.
• The market also benefits from the growing awareness about antibiotic treatments in developing regions where healthcare infrastructure is improving, leading to higher adoption rates of these drugs.
• Another significant factor is the broad spectrum of activity that sulfanilamide offers against various gram-positive and gram-negative bacteria, making it a versatile option in both hospital and community settings.
• Besides this, the cost-effectiveness of sulfanilamide, compared to newer antibiotics, makes it an attractive option in resource-limited settings, ensuring its continued demand, and thereby creating a positive outlook for market expansion.
• Moreover, the resurgence of interest in older antibiotics due to the growing problem of antibiotic resistance has led to a renewed focus on sulfanilamide as an alternative treatment option, especially in cases where other antibiotics fail or are contraindicated, which is strengthening the market growth.
• The pharmaceutical industry's efforts in research and development (R&D) to improve the formulations and delivery mechanisms of sulfanilamide, such as developing more effective topical and systemic formulations, are also contributing to the market growth.
• Concurrent with this, the ongoing advancements in pharmaceutical manufacturing processes enhancing the production efficiency and quality of sulfanilamide, driving down costs, and improving accessibility are aiding in market expansion.
• Regulatory approvals and support from government bodies for the continued use and development of sulfanilamide-based medications are providing an impetus to the market growth by encouraging pharmaceutical companies to invest in this segment.
• Additionally, the rise in healthcare expenditure globally, coupled with increasing government initiatives to combat infectious diseases, is boosting the demand for sulfanilamide as part of public health strategies.
• Furthermore, the aging population worldwide, which is more susceptible to infections due to a generally weaker immune system, creates a consistent demand for antimicrobial therapies, including sulfanilamide, bolstering the market expansion.
• Apart from this, the growing trend of self-medication and over-the-counter (OTC) availability of sulfanilamide in various formulations, such as creams, ointments, and oral tablets, makes it readily accessible to consumers, further driving the market growth.

Sulfanilamide News

The report covers the latest developments, updates, and trends impacting the global sulfanilamide market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in sulfanilamide production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that shape the industry landscape.

Latest developments in the sulfanilamide industry:

• In February 2024, Jazz Pharmaceuticals and Redx Pharma have agreed to acquire global rights to Redx's KRAS inhibitor program, with Jazz receiving an upfront $10 million payment. Redx is eligible for up to $870 million in development, regulatory, and commercial milestone payments from Jazz, with the next milestone being an IND clearance from the U.S. Food and Drug Administration.

Product Description

Sulfanilamide is a synthetic antimicrobial agent that falls under the sulfonamide class of antibiotics. These drugs were the first to be widely utilized as successful chemotherapeutics to treat bacterial infections. Its chemical structure consists of a sulfonamide group (SO₂NH₂) linked to an aniline group (an aromatic amine). Many additional sulfonamide medications, each with a different level of effectiveness and specificity for distinct bacterial illnesses, are based on this basic structure.

Sulfanilamide's mechanism of action involves the inhibition of the bacterial enzyme dihydropteroate synthase, which is crucial in the synthesis of folic acid. Bacteria need folic acid to produce essential nucleic acids (DNA and RNA) and other metabolites. By blocking this pathway, sulfanilamide prevents bacterial growth and multiplication, exerting a bacteriostatic effect.

Sulfanilamide was initially used to treat streptococcal infections, and its success led to the development of many other sulfonamide antibiotics that are used for treating UTIs, some types of meningitis, and certain forms of pneumonia, particularly in patients allergic to penicillin. Additionally, it is used in combination with other drugs to treat specific parasitic infections.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of sulfanilamide pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting sulfanilamide price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the sulfanilamide industry.